Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
12/2011
12/13/2011US8075897 Allergen peptide fragments and use thereof
12/13/2011CA2229203C Antigenic preparations from keratinophilic fungi
12/08/2011US20110301327 Epitope analogs
12/08/2011US20110300184 Pharmaceutical compositions for treating or preventing bone conditions
12/08/2011US20110300159 Sulfonated Sclerostin, antibodies, epitopes and methods for identification and use therefor
12/08/2011US20110300120 Oligosaccharide-protein conjugates
12/08/2011US20110296631 Polymeric hair dyes
12/07/2011CN102272161A 免疫原性降低的工程抗体与制备方法 Reduced immunogenicity of engineered antibody production method
12/06/2011US8071364 Gene therapy using transposon-based vectors
12/01/2011US20110295023 Dna encoding polypeptide involved in biosynthesis of herboxidiene
12/01/2011US20110294952 Optimized Drug Conjugates
12/01/2011US20110294869 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
12/01/2011US20110294118 Water soluble fluorescent compounds
12/01/2011US20110293641 A vaccinia virus protein a46 peptide and use thereof
12/01/2011US20110293597 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
11/2011
11/30/2011CN102264697A 生物合成产生的吡咯啉-羧基-赖氨酸以及通过吡咯啉-羧基-赖氨酸和吡咯赖氨酸残基化学衍生化的位点特异性蛋白修饰 Pyrroline biosynthesis produced - carboxy - lysine and by pyrroline - carboxy - pyrrol-lysine and lysine residues chemically derivatized site-specific protein modification
11/30/2011CN102260728A 一种蜂王浆多肽及其用途 Polypeptides, and uses one kind of jelly
11/30/2011CN102260727A 低分子水产胶原蛋白肽的制备方法 Preparation of low molecular weight collagen peptide Fisheries
11/29/2011US8067581 Biomolecules having multiple attachment moieties for binding to a substrate surface
11/29/2011US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium
11/29/2011US8067015 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/29/2011CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/24/2011WO2011144714A1 Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldt- jakob disease or diabetes mellitus
11/24/2011WO2007084527A8 Proteins containing a fluorinated amino acid, and methods of using same
11/24/2011US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011US20110288280 Coelenteramide analogs
11/24/2011US20110288152 Psma binding ligand-linker conjugates and methods for using
11/24/2011US20110288149 Method of protecting against heart failure
11/24/2011US20110287518 Polypeptide Purification
11/24/2011US20110287445 Mutant ROS Expression In Human Cancer
11/24/2011US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011US20110287019 Therapeutic targeting of escort proteins
11/23/2011EP2388012A1 Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus
11/23/2011EP1507787B1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/23/2011CN102250209A Novel HLA-A2 (Human Leukocyte Antigen-Alpha2) restrictive epitope polypeptide and application thereof
11/23/2011CN102250208A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011CN102250207A Novel human leukocyte antigen (HLA)-A2 limiting epitope polypeptide and use thereof
11/23/2011CN102250206A New HLA-A2 restrictive epitope polypeptide and application thereof
11/17/2011US20110283420 Plants having enhanced yield-related traits and a method for making the same
11/17/2011US20110280813 Neuraminidase inhibitors and uses thereof
11/16/2011CN102241733A Deer ossein polypeptide chelated calcium and enteric capsule and preparation method of enteric capsule
11/15/2011US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/10/2011US20110275700 Biodegradable polyketal polymers and methods for their formation and use
11/10/2011US20110275575 Peptide inhibitors of protein kinase c
11/10/2011US20110275150 Compstatin analogs with improved activity
11/10/2011US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof
11/10/2011US20110274639 Peptide-based coloring reagents for personal care
11/10/2011US20110274618 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
11/08/2011US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011US8053554 Peptide nanostructures and methods of generating and using the same
11/08/2011US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/03/2011US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011US20110269814 2'-f modified rna interference agents
11/03/2011US20110269670 Carbohydrate binding molecules
11/03/2011US20110269231 Proteoglycan-binding peptides that modulate stem cell behavior
11/03/2011US20110268903 Methods of attaching biological compounds to solid supports using triazine
11/02/2011CN102229972A Preparation method for collagen peptides from tree frog skin
11/01/2011US8048988 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
11/01/2011US8048987 Polypeptides having DNA polymerase activity
11/01/2011US8048984 Human GIL-19/AE289 proteins
10/2011
10/27/2011US20110263821 Prognosis and risk assessment in stroke patients by determining the level of marker peptides
10/27/2011US20110263815 Triazole macrocycle systems
10/27/2011US20110263681 Organic Compositions to Treat Beta-ENaC-Related Diseases
10/27/2011US20110263450 Alzheimer's disease biomarkers
10/27/2011US20110263042 Assay method for antibodies against cyclic citrullinated peptide
10/27/2011US20110262964 Reagentless fluorescent biosensors comprising a designed ankyrin repeat protein module, rational design methods to create reagentless fluorescent biosensors and methods of their use
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/20/2011US20110257043 Ultra high-throughput opti-nanopore dna readout platform
10/20/2011US20110256534 Prediction of antiviral therapy response
10/20/2011US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof
10/20/2011US20110256088 Targeted delivery of nucleic acids
10/20/2011US20110256060 Monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therpay
10/19/2011CN101643767B Method for preparing almond peptide from almond dregs
10/18/2011US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/13/2011US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011US20110250685 Compositions and methods for enhancing cellular transport of biomolecules
10/13/2011US20110250222 Antigenic polypeptides of chlamydia-related bacteria for diagnosis and vaccine
10/13/2011US20110250217 Methods and compositions for eliciting an amyloid-selective immune response
10/13/2011US20110250132 Lipoic acid metabolite: useful for drug carrier, nanoparticle conjugate, imaging and hyperthermia therapy
10/13/2011US20110247404 Identifying and quantifying biomarkers associated with preeclampsia
10/11/2011US8034349 Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide
10/11/2011CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/06/2011US20110245458 Peptide nucleic acid monomers and oligomers
10/06/2011US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED
10/06/2011US20110243986 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
10/06/2011US20110243923 Organic compounds
10/06/2011US20110243857 Smart contrast agents for mri imaging
10/05/2011EP2371838A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011EP2371837A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011EP2371836A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011EP2016092B1 Compositions and methods for modulating the immune system
10/05/2011CN102205338A Chemical method for treating epidemic disease infected animal corpse
10/04/2011US8030096 Water-soluble rhodamine dyes conjugates
09/2011
09/29/2011US20110239311 Agonists of NR2F6 For Immunosupression
09/29/2011US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
09/29/2011US20110237493 Dipeptide linked medicinal agents
09/29/2011US20110236952 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof
09/29/2011US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 48